Cytogenetic and Genome Research
Imprinted Genes/Domains
The H19 gene: regulation and function of a non-coding RNAGabory A. · Ripoche M.-A. · Yoshimizu T. · Dandolo L.Department of Genetics and Development, Institut Cochin, INSERM U567, CNRS UMR 8104, University Paris V Descartes, Paris (France)
|
|
Cytogenet Genome Res 113:188–193 (2006)
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
First-Page Preview
Published online: March 30, 2006
Issue release date: March 2006
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 0
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Abstract
The H19 gene encodes a 2.3-kb non-coding mRNA which is strongly expressed during embryogenesis. This gene belongs to an imprinted cluster, conserved on mouse chromosome 7 and human chromosome 11p15. H19 is maternally expressed and the neighbouring Igf2 gene is transcribed from the paternal allele. These two genes are co-expressed in endoderm- and mesoderm-derived tissues during embryonic development, which suggests a common mechanism of regulation. The regulatory elements (imprinted con- trol region, CTCF insulation, different enhancer sequences, promoters of the two genes, matrix attachment regions) confer a differential chromatin architecture to the two parental alleles leading to reciprocal expression. The role of the H19 gene is unclear but different aspects have been proposed. H19 influences growth by way of a cis control on Igf2 expression. Although H19–/– mice are viable, a role for this gene during development has been suggested by viable H19–/– parthenogenetic mice. Finally it has been described as a putative tumour suppressor gene. H19 has been studied by numerous laboratories over the last fifteen years, nevertheless the function of this non-coding RNA remains to be elucidated.
© 2006 S. Karger AG, Basel
Related Articles:
References
- Ainscough JF, Koide T, Tada M, Barton S, Surani MA: Imprinting of Igf2 and H19 from a 130-kb YAC transgene. Development 124:3621–3632 (1997).
- Ainscough JF, Dandolo L, Surani MA: Appropriate expression of the mouse H19 gene utilises three or more distinct enhancer regions spread over more than 130 kb. Mech Dev 91:365–368 (2000).
- Arney KL: H19 and Igf2 – enhancing the confusion? Trends Genet 19:17–23 (2003).
- Banerjee S, Smallwood A: A chromatin model of IGF2/H19 imprinting. Nat Genet 11:237–238 (1995).
- Bartolomei MS, Zemel S, Tilghman SM: Parental imprinting of the mouse H19 gene. Nature 351:153–155 (1991).
- Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM: Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev 7:1663–1673 (1993).
- Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405:482–485 (2000).
- Brannan CI, Dees EC, Ingram RS, Tilghman SM: The product of the H19 gene may function as an RNA. Mol Cell Biol 10:28–36 (1990).
- Charalambous M, Menheniott TR, Bennett WR, Kelly SM, Dell G, Dandolo L, Ward A: An enhancer element at the Igf2/H19 locus drives gene expression in both imprinted and non-imprinted tissues. Dev Biol 271:488–497 (2004).
- Dao D, Walsh CP, Yuan L, Gorelov D, Feng L, Hensle T, Nisen PY, Yamashiro DJ, Bestor TH, Tycko B: Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms’ tumorigenesis and methylation hyper-dependence of H19 imprinting. Hum Mol Genet 8:1337–1352 (1999).
- Davies K, Bowden L, Smith P, Dean W, Hill D, Furuumi H, Sasaki H, Cattanach B, Reik W: Disruption of mesodermal enhancers for Igf2 in the minute mutant. Development 129:1657–1668 (2002).
- Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987–1000 (1987).
- Davis TL, Trasler JM, Moss SB, Yang GJ, Bartolomei MS: Acquisition of the H19 methylation imprint occurs differentially on the parental alleles during spermatogenesis. Genomics 58:18–28 (1999).
- Davis TL, Yang GJ, McCarrey JR, Bartolomei MS: The H19 methylation imprint is erased and re-established differentially on the parental alleles during male germ cell development. Hum Mol Genet 9:2885–2894 (2000).
- Drewell RA, Brenton JD, Ainscough JF, Barton SC, Hilton KJ, Arney KL, Dandolo L, Surani MA: Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switch. Development 127:3419–3428 (2000).
- Drewell RA, Arney KL, Arima T, Barton SC, Brenton JD, Surani MA: Novel conserved elements upstream of the H19 gene are transcribed and act as mesodermal enhancers. Development 129:1205–1213 (2002).
-
Ferguson-Smith AC, Sasaki H, Cattanach BM, Surani MA: Parental-origin-specific epigenetic modifications of the mouse H19 gene. Nature 362:751–755 (1993).
- Forne T, Oswald J, Dean W, Saam JR, Bailleul B, Dandolo L, Tilghman SM, Walter J, Reik W: Loss of the maternal H19 gene induces changes in Igf2 methylation in both cis and trans. Proc Natl Acad Sci USA 94:10243–10248 (1997).
- Frevel MA, Sowerby SJ, Petersen GB, Reeve AE: Methylation sequencing analysis refines the region of H19 epimutation in Wilms’ tumor. J Biol Chem 274:29331–29340 (1999).
- Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, Reik W, Walter J, Surani MA: Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 117:15–23 (2002).
- Hansen TV, Hammer NA, Nielsen J, Madsen M, Dalbaeck C, Wewer UM, Christiansen J, Nielsen FC: Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol 24:4448–4464 (2004).
- Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B: Tumour-suppressor activity of H19 RNA. Nature 365:764–767 (1993).
- Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM: CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486–489 (2000).
- Ishihara K, Hatano N, Furuumi H, Kato R, Iwaki T, Miura K, Jinno Y, Sasaki H: Comparative genomic sequencing identifies novel tissue-specific enhancers and sequence elements for methylation-sensitive factors implicated in Igf2/H19 imprinting. Genome Res 10:664–671 (2000).
- Jones BK, Levorse JM, Tilghman SM: Igf2 imprinting does not require its own DNA methylation or H19 RNA. Genes Dev 12:2200–2207 (1998).
- Jones BK, Levorse J, Tilghman SM: Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum Mol Genet 10:807–814 (2001).
- Juan V, Crain C, Wilson C: Evidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA. Nucleic Acids Res 28:1221–1227 (2000).
- Kaffer CR, Srivastava M, Park KY, Ives E, Hsieh S, Batlle J, Grinberg A, Huang SP, Pfeifer K: A transcriptional insulator at the imprinted H19/Igf2 locus. Genes Dev 14:1908–1919 (2000).
- Kanduri C, Pant V, Loukinov D, Pugacheva E, Qi CF, Wolffe A, Ohlsson R, Lobanenkov VV: Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 10:853–856 (2000).
- Kato Y, Sasaki H: Imprinting and looping: epigenetic marks control interactions between regulatory elements. Bioessays 27:1–4 (2005).
- Kono T, Obata Y, Yoshimzu T, Nakahara T, Carroll J: Epigenetic modifications during oocyte growth correlates with extended parthenogenetic development in the mouse. Nat Genet 13:91–94 (1996).
- Kono T, Sotomaru Y, Katsuzawa Y, Dandolo L: Mouse parthenogenetic embryos with monoallelic H19 expression can develop to day 17.5 of gestation. Dev Biol 243:294–300 (2002).
- Kono T, Obata Y, Wu Q, Niwa K, Ono Y, Yamamoto Y, Park ES, Seo JS, Ogawa H: Birth of parthenogenetic mice that can develop to adulthood. Nature 428:860–864 (2004).
- Lee JE, Pintar J, Efstratiadis A: Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 110:151–159 (1990).
- Lee J, Inoue K, Ono R, Ogonuki N, Kohda T, Kaneko-Ishino T, Ogura A, Ishino F: Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells. Development 129:1807–1817 (2002).
- Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM: Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34–39 (1995a).
- Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM: An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 9:2079–2089 (1995b).
- Li JY, Lees-Murdock DJ, Xu GL, Walsh CP: Timing of establishment of paternal methylation imprints in the mouse. Genomics 84:952–960 (2004).
- Li YM, Franklin G, Cui HM, Svensson K, He XB, Adam G, Ohlsson R, Pfeifer S: The H19 transcript is associated with polysomes and may regulate IGF2 expression in trans. J Biol Chem 273:28247–28252 (1998).
- Lopes S, Lewis A, Hajkova P, Dean W, Oswald J, Forne T, Murrell A, Constância M, Bartolomei M, Walter J, et al: Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions. Hum Mol Genet 12:295–305 (2003).
- Lucifero D, Mertineit C, Clarke HJ, Bestor TH, Trasler JM: Methylation dynamics of imprinted genes in mouse germ cells. Genomics 79:530–538 (2002).
- Maher ER, Reik W: Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J Clin Invest 105:247–252 (2000).
- Murrell A, Heeson S, Reik W: Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 36:889–893 (2004).
- Obata Y, Kaneko-Ishino T, Koide T, Takai Y, Ueda T, Domeki I, Shiroishi T, Ishino F, Kono T: Disruption of primary imprinting during oocyte growth leads to the modified expression of imprinted genes during embryogenesis. Development 125:1553–1560 (1998).
- Obata Y, Kono T, Hatada I: Gene silencing: maturation of mouse fetal germ cells in vitro. Nature 418:497 (2002).
- Pachnis V, Brannan CI, Tilghman SM: The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J 7:673–681 (1988).
- Poirier F, Chan C-TJ, Timmons PM, Robertson EJ, Evans MJ, Rigby PWJ: The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 113:1105–1114 (1991).
- Prawitt D, Enklaar T, Gartner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, et al: Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms’ tumor. Proc Natl Acad Sci USA 102:4085–4090 (2005).
- Purbowasito W, Suda C, Yokomine T, Zubair M, Sado T, Tsutsui K, Sasaki H: Large-scale identification and mapping of nuclear matrix-attachment regions in the distal imprinted domain of mouse chromosome 7. DNA Res 11:391–407 (2004).
- Ripoche MA, Kress C, Poirier F, Dandolo L: Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev 11:1596–1604 (1997).
- Runge S, Nielsen FC, Nielsen J, Lykke-Andersen J, Wewer UM, Christiansen J: H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem 275:29562–29569 (2000).
- Sasaki H, Ferguson-Smith AC, Shum ASW, Barton SC, Surani MA: Temporal and spatial regulation of H19 imprinting in normal and uniparental mouse embryos. Development 121:4195–4202 (1995).
- Schmidt JV, Levorse JM, Tilghman SM: Enhancer competition between H19 and Igf2 does not mediate their imprinting. Proc Natl Acad Sci USA 96:9733–9738 (1999).
- Sparago A, Cerrato F, Vernucci M, Ferrero GB, Silengo MC, Riccio A: Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 36:958–960 (2004).
- Srivastava M, Hsieh S, Grinberg A, Williams-Simons L, Huang SP, Pfeifer K: H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19. Genes Dev 14:1186–1195 (2000).
- Sun FL, Dean WL, Kelsey G, Allen ND, Reik W: Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389:809–815 (1997).
- Szabó PE, Mann JR: Allele-specific expression and total expression levels of imprinted genes during early mouse development: Implications for imprinting mechanisms. Genes Dev 9:3097–3108 (1995a).
- Szabó PE, Mann JR: Biallelic expression of imprinted genes in the mouse germ line: Implications for erasure establishment and mechanisms of genomic imprinting. Genes Dev 9:1857–1868 (1995b).
- Szabó P, Tang SH, Rentsendorj A, Pfeifer GP, Mann JR: Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr Biol 10:607–610 (2000).
- Szabó PE, Hubner K, Scholer H, Mann JR: Allele-specific expression of imprinted genes in mouse migratory primordial germ cells. Mech Dev 115:157–160 (2002).
- Szabó PE, Tang SH, Silva FJ, Tsark WM, Mann JR: Role of CTCF binding sites in the Igf2/H19 imprinting control region. Mol Cell Biol 24:4791–4800 (2004).
- Thorvaldsen JL, Duran KL, Bartolomei MS: Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev 12:3693–3702 (1998).
- Thorvaldsen JL, Mann MR, Nwoko O, Duran KL, Bartolomei MS: Analysis of sequence upstream of the endogenous H19 gene reveals elements both essential and dispensable for imprinting. Mol Cell Biol 22:2450–2462 (2002).
- Tremblay KD, Saam JR, Ingram RS, Tilghman SM, Bartolomei MS: A paternal-specific methylation imprint marks the alleles of the mouse H19 gene. Nat Genet 9:407–413 (1995).
- Tremblay KD, Duran K, Bartolomei M: A 5′ 2-kilobase-pair region of the imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol Cell Biol 17:4322–4329 (1997).
- Ueda T, Abe K, Miura A, Yuzuriha M, Zubair M, Noguchi M, Niwa K, Kawase Y, Kono T, Matsuda Y, et al: The paternal methylation imprint of the mouse H19 locus is acquired in the gonocyte stage during foetal testis development. Genes Cells 5:649–659 (2000).
- Weber M, Milligan L, Delalbre A, Antoine E, Brunel C, Cathala G, Forne T: Extensive tissue-specific variation of allelic methylation in the Igf2 gene during mouse fetal development: relation to expression and imprinting. Mech Dev 101:133–141 (2001).
- Weber M, Hagege H, Murrell A, Brunel C, Reik W, Cathala G, Forne T: Genomic imprinting controls matrix attachment regions in the Igf2 gene. Mol Cell Biol 23:8953–8959 (2003).
- Wiles MV: Isolation of differentially expressed human cDNA clones: similarities between mouse and human embryonal carcinoma cell differentiation. Development 104:403–413 (1988).
- Wilkin F, Paquette J, Ledru E, Hamelin C, Pollak M, Deal CL, Hamelin C: H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels. Eur J Biochem 267:4020–4027 (2000).
- Yoo-Warren H, Pachnis V, Ingram RS, Tilghman SM: Two regulatory domains flank the mouse H19 gene. Mol Cell Biol 8:4707–4715 (1988).
- Zhang Y, Tycko B: Monoallelic expression of the human H19 gene. Nat Genet 1:40–44 (1992).
Article / Publication Details
First-Page Preview
Published online: March 30, 2006
Issue release date: March 2006
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 0
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Article Tools
PubMed IDArticle Details
Recommend This
Additional Information
Supported by the INSERM, by an Action Concertée Incitative (ACI Biologie du Développement), by the Association de Recherche contre le Cancer (ARC) and by the AFM. A.G. is supported by a fellowship from the Ministère de la Recherche et de l’Education Nationale, T.Y. was supported by a post-doctoral fellowship from the Institut National pour la Santé et la Recherche Médicale (INSERM) and from the Association Française contre les Myopathies (AFM).
